TrialESMO open2025

Neoadjuvant chemotherapy with FOLFOXIRI for high-risk relapsed locally advanced colon cancer: a single-arm phase II trial.

Yu-Wen Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.